These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17520889)

  • 1. [Rabeprazole test and comparison of the effectiveness of course treatment with rabeprazole in patients with gastroesophageal reflux disease and non-coronary chest pain].
    Maev IV; Iurenev GL; Burkov SG; V'iuchnova ES
    Klin Med (Mosk); 2007; 85(2):45-51. PubMed ID: 17520889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.
    Kim JH; Sinn DH; Son HJ; Kim JJ; Rhee JC; Rhee PL
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1504-9. PubMed ID: 19467139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage)].
    Vasil'ev IuV; Noskova KK; Zelenikin SA
    Eksp Klin Gastroenterol; 2002; (1):55-60, 190. PubMed ID: 12271586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Esomeprasol and rabeprasol effects on esophageal acidification in patients with gastroesophageal reflux disease, intensively metabolizing inhibitors of proton pump].
    Morozov SV; Tsodikova OM; Isakov VA; Tereshchenko SG; Gushchin AE; Shipulin GA
    Ter Arkh; 2005; 77(2):21-5. PubMed ID: 15807445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis.
    Wang WH; Huang JQ; Zheng GF; Wong WM; Lam SK; Karlberg J; Xia HH; Fass R; Wong BC
    Arch Intern Med; 2005 Jun; 165(11):1222-8. PubMed ID: 15956000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton pump inhibition: more than only reflux therapy].
    MMW Fortschr Med; 2008 Nov; 150(46):48-9. PubMed ID: 19133361
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
    Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.
    Lim PW; Goh KL
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S61-8. PubMed ID: 15324384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis.
    Cremonini F; Wise J; Moayyedi P; Talley NJ
    Am J Gastroenterol; 2005 Jun; 100(6):1226-32. PubMed ID: 15929749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
    Kahrilas PJ; Hughes N; Howden CW
    Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
    Archimandritis AJ; Nikolopoulou V; Kouklakis G; Paraskevas E; Avgerinos A; Tsianos E; Triantafillidis JK;
    Curr Med Res Opin; 2005 Apr; 21(4):603-10. PubMed ID: 15899110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ; Boer WA; Geldof H; Hazelhoff B; Bergmans P; Tytgat GN; Smout AJ
    Aliment Pharmacol Ther; 2004 Aug; 20(4):451-8. PubMed ID: 15298640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial.
    Budzyński J; Kłopocka M; Pulkowski G; Suppan K; Fabisiak J; Majer M; Swiatkowski M
    Int J Cardiol; 2008 Jul; 127(2):233-9. PubMed ID: 17689732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.